Rating History for Pharmacyclics (PCYC) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for PCYC
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/27/2015 N/A Downgrade Neutral
(Buy)		 N/A
(N/A)		 217.82
(261.25)		 19.94% Details